FEMY Femasys Inc.
Femasys Inc. (FEMY) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: August 7, 2026 , by Elefant Dov .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Elefant Dov | Chief Financial Officer | Buy | 15,625 | $3.20 | $50.0K | 15,625 | |
| Lee-Sepsick Kathy | Chief Executive Officer | Buy | 15,625 | $3.20 | $50.0K | 15,625 | |
| Canning John Charles | Chief Operating Officer | Buy | 4,375 | $3.20 | $14.0K | 4,375 | |
| Mifek Jeffrey Gerald | Chief Clinical-Medical Affairs | Buy | 3,125 | $3.20 | $10.0K | 3,125 | |
| Sipos Jeremy Alexander | Chief Technology Officer | Buy | 3,125 | $3.20 | $10.0K | 3,125 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.